Tag: medtronic

4 articles

Market Moves

Medtronic to acquire SPR Therapeutics for $650 million as top-three neuromodulation incumbents consolidate the peripheral nerve stim category

Medtronic announced on 20 May 2026 its intent to acquire SPR Therapeutics, the maker of the Sprint percutaneous peripheral nerve stimulation system, for approximately $650 million in upfront cash. The deal is the second top-three neuromodulation acquisition of a PNS specialist in seven months, after Boston Scientific completed its $533 million purchase of Nalu Medical in January 2026.

May 21

Industry News

UChicago Medicine joins Precision Neuroscience's clinical research network with Layer 7 sensorimotor partnership

Precision Neuroscience and UChicago Medicine announced on April 30 the launch of a clinical research partnership focused on AI-driven sensorimotor function and neuroprosthetics. The collaboration uses Precision's Layer 7 Cortical Interface, the FDA 510(k)-cleared high-density microelectrode array, and is the second material Precision institutional move of 2026, following the company's January integration with Medtronic's StealthStation surgical navigation system.

Apr 30